DrugDashboards

Bromfenac

Bromfenac · BROMFENAC SODIUM .9 mg/mL · Solution/ Drops · Ophthalmic · Aurobindo Pharma Limited

NDC 65862-0789-17 · 1 BOTTLE in 1 CARTON / 1.7 mL in 1 BOTTLE · ANDA · View full market →

The short version

8 companies supply this market — a reasonable cushion if one runs into trouble. The generic price is down 30% over the past year, to $15.67 per mL. The brand (Bromsite 0.075%) runs $49.55 per mL 2.5× more. One of its named manufacturing plants, Eugia Pharma Specialities Limited, failed FDA inspectionwithin the last two years — the agency’s most serious outcome. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$50.00$100.00May 2023Sep 2026$15.67
41 price points · per MLSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$142.46
Reported to Texas DSHS · 2026 annual filing · Aurobindo Pharma Usa, Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2024)

$2,154
30 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

8Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • price down 27% year over year+8

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for bromfenac (other) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA204813
TE code
AT2
Approval date
Mar 18, 2022
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Bromfenac (Solution/ Drops)

LabelerStrengthFirst seenLast seen
Alembic Pharmaceuticals LimitedBROMFENAC SODIUM 1.035 mg/mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals NY LLCBROMFENAC SODIUM .7 mg/mLJul 15, 2026Sep 2, 2026
Armas Pharmaceuticals Inc.BROMFENAC SODIUM 1.035 mg/mLJul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedBROMFENAC SODIUM .9 mg/mLJul 15, 2026Sep 2, 2026
Fosun Pharma USA Inc.BROMFENAC SODIUM .9 mg/mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedBROMFENAC SODIUM .9 mg/mLJul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals, Inc.BROMFENAC SODIUM .75 mg/mLJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.BROMFENAC SODIUM .76 mg/mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Bromfenac — NDC 65862-0789-17," retrieved September 3, 2026, https://drugdashboards.com/drug/65862078917.

Free to cite with attribution — see how the data is put together.